Loading organizations...
Key people at CBC Co. Japan.
Headquartered in Tokyo, Japan, CBC is a diversified trading and manufacturing enterprise that produces synthetic resins, chemicals, pharmaceuticals, agrochemicals, foods, and optical products. The global organization generates approximately 2.1 billion dollars in annual sales and maintains a dedicated workforce of over 2,700 employees across its international divisions. Operating as both a traditional Japanese shosha and a specialized manufacturer, the firm connects domestic and overseas markets through an extensive network of production facilities and export subsidiaries. Its manufacturing footprint spans multiple countries, including the United States, Italy, Bangladesh, Thailand, and China, supporting specialized product lines such as machine vision optics and surveillance camera lenses marketed under the Computar brand. The company was originally founded as Doi Utaro Shoten in 1925 by Doi Utaro, before eventually reorganizing as Chugai Boeki and adopting its current corporate name in 1999.
Key people at CBC Co. Japan.
CBC Co., Ltd. is a Tokyo-headquartered Japanese trading and manufacturing company established in 1925, operating as a "development-type creative trading company" that fuses shosha (trading) functions with manufacturing.[1][2][7] It specializes in synthetic resins, chemicals, pharmaceuticals, agrochemicals, foods, electronics components, optical equipment, industrial machinery, solar & fuel cells, elder care, and textiles, with manufacturing focused on pharmaceutical intermediates, active pharmaceutical ingredients (APIs), optical lenses, and vapor deposition coatings.[2][7] The company reported sales of 249,233 million yen in 2025 (up from 225,287 million in 2024), income before taxes of 20,709 million yen, and employs 379 people (2,048 consolidated) as of March 2025, with 43 bases across 18 countries.[1][2]
Guided by its philosophy of "Co-existence and Co-prosperity"—"Dream Together"—CBC emphasizes sustainable growth, employee prosperity, community development, and global expansion into high-growth areas like pharmaceuticals and electronics.[1][7] It serves diverse end-users from automotive and IT sectors to healthcare and food, solving supply chain needs through integrated trading-manufacturing support, procurement, and value-added solutions like niche farming (e.g., CBC AOZORA FARM).[2][7]
CBC traces its roots to January 20, 1925, when it was founded as Doi Utaro Shoten and quickly reorganized into Chugai Boyeki Gomei Kaisha, a chemicals trading firm.[1][2] The first president instilled "romanticism" into the company principles, prioritizing employee and community prosperity via sustainable growth, evolving it into a bold "shosha-style" entity.[1]
Pivotal shifts included entering manufacturing via an optical business M&A, balancing trading with production in automotive/electronics materials, IT/robotics, and booming pharmaceuticals.[1] Renamed CBC Co., Ltd. in February 1999 (from Chugai Boyeki Company initials) to signal globalization, it has grown to 45+ worldwide locations while retaining its core philosophy.[1][2][7] Recent milestones include SBTi certification, a Korea joint venture, and farm launches, approaching its 2025 centennial with strong financial momentum.[2][7]
(Note: References to "CBC Group" in some sources describe distinct entities like a Singapore/China healthcare investor or VC, not this Japanese firm.[3][4][5][6])
CBC rides trends in pharmaceutical manufacturing, electronics, and renewables (e.g., solar/fuel cells), capitalizing on global supply chain shifts post-pandemic and Japan's push for advanced materials/IT-robotics.[1][2][7] Timing aligns with aging populations boosting pharma/APIs demand and electronics growth in Asia, where its manufacturing bases (e.g., China, Thailand) provide flexibility amid US-China tensions.[1][2]
Market forces like sustainability (SBTi certification) and localization favor its "proximity to end-users" model, influencing ecosystems by bridging trading efficiency with manufacturing innovation—e.g., optical devices for tech and elder care solutions.[2][7] As a century-old player, it shapes Japan's "shosha evolution" into creative, global manufacturers, supporting SMEs via networks and M&A expertise.[1]
CBC's next phase targets 100th anniversary growth via pharma acceleration, global JVs (e.g., Korea), and sustainability, building on 2025's record sales/profits.[2][7] Trends like AI-driven robotics, green energy, and biotech localization will propel it, with its nimble, integrated model mitigating risks in volatile chains.
Influence may expand as a go-to partner for tech-material fusion, evolving from trader to innovator—echoing its origin as a bold chemicals pioneer now thriving globally under "Dream Together."[1]
